Lam Research LRCX Earns Analyst Upgrades as an Oversold Growth Stock Candidate US Treasury Yield Surge Reshapes Risk Perceptions for Bond Investors Viridian Therapeutics Prices Upsized 350M Concurrent Public Offerings Hexagon Nutrition IPO Opens June 5 at Rs 4245 Band Aims to Raise Rs 13887 Crore US Prioritizes AI Integration in Asia Following TrumpXi Summit BlueCollar Workers Emerge as Winners in AI Economy ATT CEO Says Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances Unity Software Q1 2026 Earnings Narrower Loss Beats Estimates Stock Edges Higher Mount Logan Capital Inc Q1 2026 Earnings Net Loss Reported Amid Strategic Positioning RingCentral Q1 2026 Earnings EPS Beats Estimates as Stock Rises 313 EyePoint Inc EYPT Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Titan Mining Q1 2026 Earnings Strong EPS Surprise Despite Absent Revenue Data Kartoon Studios TOON Slides 286 as Stock Tests Key Support Near 065 ENJ Bonds Edge Higher as Entergy New Orleans 50 Series Approaches Resistance Steady Demand in FixedIncome Market KE Holdings BEKE Inches Higher Amid Stabilizing Volume and Key Technical Levels Eaton Vance Global Dividend Income Fund ETG Edges Higher Approaching Resistance at 2413 CanFite Biopharma CANF Slips 32 as Stock Tests Key Support Level Churchill Downs CHDN Surges Over 5 Breaking Above Support Eyeing Resistance CCU Stock Gains 225 as Chilean Brewer Holds Above Key Support Blue Water Acquisition Corp III BLUW Holds Steady Near NAV Amid Quiet Trading Summit Midstream Corporation SMC Pulls Back From Resistance Key Support Levels in Focus Proficient Auto Logistics PAL Gains 276 as Buyers Defend Support at 495 Barings Corporate Investors MCI Edges Lower Holding Near Support Levels Oppenheimer Initiates Coverage on Martin Marietta Materials with Perform Rating AMBR Q4 2025 Earnings EPS Misses Estimates by Narrow Margin Stock Gains Vishay Precision Group VPG Surges 93 Breaking Through Key Resistance Levels OLMA Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances IIIN Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises Accuray ARAY Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Unreported C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage UNIVERSAL INSURANCE HOLDINGS INC UVE Q1 2026 Earnings Strong EPS Beat Drives 4246 Surprise Stock Slides GLIBA Q1 2026 Earnings Significant Earnings Miss as EPS Falls Well Below Estimates LGCY Q1 2026 Earnings EPS Beats Estimates by 244 Revenue Not Disclosed